英国国家医疗服务体系（NHS England）将29家医院信托机构列为“从Palantir数据平台中获益”的机构。这些信托机构表示，该系统尚未上线，或者他们不使用其任何应用。罗伯特·布斯（Robert Booth）周一为《卫报》报道了上述调查结果。
NHS England lists 29 hospital trusts as “realising benefits” from Palantir’s data platform. Those trusts say the system is not live, or that they do not use any of its applications. Robert Booth reported the findings for the Guardian on Monday.
这些答案来自超过100份信息自由请求。医学慈善机构Medact提交了这些请求，并将其分享给《卫报》。该组织主张将Palantir从NHS中移除。TNW未能独立核实这些回复。
The answers came from more than 100 freedom of information requests. Medact, a medical charity that campaigns to remove Palantir from the NHS, filed them and shared them with the Guardian. TNW has not independently verified the responses.
《卫报》报道称，一位高级卫生官员将NHS England的说法与信托机构的回答之间的差距称为“非常具有误导性”。
One senior health official called the gap between NHS England’s claim and the trusts’ answers “very misleading”, the Guardian reported.
信托机构的说法与NHS England的数据 NHS England的数据显示，142家信托机构已在Palantir NHS数据平台上线，137家正在报告获益。这项耗资3.3亿英镑的联邦数据平台于2024年4月开始推广，旨在连接分散的医疗记录，加快医院出院速度，并改善手术排程。
What the trusts said NHS England’s own figures say 142 trusts are live on the Palantir NHS data platform and 137 are reporting benefits. The £330m federated data platform began rolling out in April 2024. It aims to join up scattered medical records, speed up hospital discharges and improve surgery scheduling.
埃普瑟姆和圣赫利尔（Epsom and St Helier）表示，目前“未使用FDP”。默西护理（Mersey Care）表示“尚未上线”，诺丁汉大学医院（Nottingham University Hospitals）表示“尚未达成实施时间表”。
Epsom and St Helier said it was “not using FDP at the moment”. Mersey Care said it had “not yet gone live”, and Nottingham University Hospitals said “no implementation timeline has been agreed”.
北米德兰兹大学医院（University Hospitals of North Midlands）表示：“FDP未上线。我们无意在未来推广。”
“FDP is not live. We do not intend to roll it out in the future,” University Hospitals of North Midlands said.
NHS England和Palantir的回应 NHS England表示，近140家信托机构“已报告从平台上提供的各种工具中获益，帮助员工整合并改善患者护理，并更高效地工作”。
NHS England and Palantir respond Nearly 140 trusts “have now reported benefits from the wide range of tools available on the platform, helping staff join up and improve care for patients, and work more efficiently,” NHS England said.
NHS England此前曾表示，其名单包括使用这些工具进行后台数据工作而非患者护理的信托机构。《卫报》报道了这一点。例如，托贝和南德文（Torbay and South Devon）表示，目前“未在运营中使用FDP”。NHS England将其列为上线状态，因为提交数据的系统已就绪。
NHS England has said before that its list includes trusts that use the tools for back-office data work, not for patient care. The Guardian reported that point. Torbay and South Devon, for example, said it is “not currently operationally using the FDP”. NHS England counts it as live because the systems for submitting data are in place.
一位Palantir发言人表示：“Palantir软件正在帮助提供更好的护理，使用该软件的信托机构记录了117,000例额外手术。”
“Palantir software is helping to deliver better care, with trusts using it recording 117,000 additional operations,” a Palantir spokesperson said.
英国国家医疗服务体系（NHS England）的数据是前后对比。其网站表示，无法从中得出“因果关系”的结论。据《卫报》报道，统计监管局将审查“实现效益”的说法。
NHS England’s figures are before-and-after comparisons. Its website says it “cannot draw conclusions about cause and effect” from them. The Office for Statistics Regulation will now look at the “realising benefits” claim, according to the Guardian.
要求终止合同 奇·奥努瓦拉担任下议院科学技术委员会主席。她希望政府使用帕兰蒂尔合同中2027年的终止条款。她还希望为一家英国供应商进行公开竞争。下议院卫生委员会也呼吁部长终止该交易。
Calls to end the contract Chi Onwurah chairs the Commons science and technology committee. She wants the government to use the 2027 break clause in Palantir’s contract. She also wants an open competition for a UK-based supplier. The Commons health committee is also calling for ministers to end the deal.
“如果许多NHS信托机构看不到FDP的价值，就需要认真质疑围绕帕兰蒂尔产品的炒作是否与现实相符，”奥努瓦拉说。
“If many NHS trusts don’t see the value of the FDP, serious questions need to be asked about whether the hype surrounding Palantir’s products matches reality,” Onwurah said.
帕兰蒂尔英国和欧洲首席执行官路易斯·莫斯利表示，终止合同将是“将政治置于患者之上”。帕兰蒂尔已聘请前工党副领袖汤姆·沃森担任游说人员。9月，44000人对该平台表示反对。
Louis Mosley, Palantir’s chief executive for the UK and Europe, said ending the contract would be “putting politics above patients”. Palantir has hired the former Labour deputy leader Tom Watson as a lobbyist. In September, 44,000 people objected to the platform.